




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
小半夏湯防治四肢良性骨腫瘤全麻術(shù)后痰飲內(nèi)停型惡心嘔吐的臨床療效觀察摘要:目的:觀察小半夏湯對(duì)四肢良性骨腫瘤全麻術(shù)后痰飲內(nèi)停型惡心嘔吐的臨床療效。方法:選取2019年1月至2020年12月我院收治的89例四肢良性骨腫瘤患者,隨機(jī)分為小半夏湯組和對(duì)照組,每組各44例。小半夏湯組給予小半夏湯治療,對(duì)照組給予常規(guī)治療,比較兩組治療效果。結(jié)果:小半夏湯組總有效率為97.73%,對(duì)照組總有效率為84.09%,兩組比較有顯著性差異(P<0.05)。小半夏湯組的恢復(fù)時(shí)間顯著短于對(duì)照組(P<0.05)。小半夏湯組術(shù)后惡心嘔吐的發(fā)生率明顯降低于對(duì)照組(P<0.05)。小半夏湯組對(duì)惡心嘔吐的緩解率明顯優(yōu)于對(duì)照組(P<0.05)。結(jié)論:小半夏湯能夠顯著降低四肢良性骨腫瘤全麻術(shù)后痰飲內(nèi)停型患者的惡心嘔吐的發(fā)生率,提高惡心嘔吐的緩解率,縮短術(shù)后恢復(fù)時(shí)間。
關(guān)鍵詞:四肢良性骨腫瘤;小半夏湯;全麻術(shù)后痰飲內(nèi)停型;惡心嘔吐;臨床療效觀察。
Abstract:Objective:ToobservetheclinicalefficacyofXiaobanxiatanginpreventingandtreatingnauseaandvomitingaftergeneralanesthesiainpatientswithbenignbonetumorsofthelimbs.Methods:Eighty-ninepatientswithbenignbonetumorsofthelimbsadmittedtoourhospitalfromJanuary2019toDecember2020wererandomlydividedintoXiaobanxiatanggroupandcontrolgroup,with44patientsineachgroup.TheXiaobanxiatanggroupwastreatedwithXiaobanxiatang,whilethecontrolgroupwastreatedwithconventionaltreatment.Thetherapeuticeffectsofthetwogroupswerecompared.Results:ThetotaleffectiverateoftheXiaobanxiatanggroupwas97.73%,andthatofthecontrolgroupwas84.09%.Therewasasignificantdifferencebetweenthetwogroups(P<0.05).TherecoverytimeoftheXiaobanxiatanggroupwassignificantlyshorterthanthatofthecontrolgroup(P<0.05).TheincidenceofpostoperativenauseaandvomitingintheXiaobanxiatanggroupwassignificantlylowerthanthatinthecontrolgroup(P<0.05).TheXiaobanxiatanggrouphadasignificantlyhigherreliefrateofnauseaandvomitingthanthecontrolgroup(P<0.05).Conclusion:Xiaobanxiatangcansignificantlyreducetheincidenceofnauseaandvomitinginpatientswithbenignbonetumorsofthelimbsaftergeneralanesthesia,improvethereliefrateofnauseaandvomiting,andshortenthepostoperativerecoverytime.
Keywords:Benignbonetumorsofthelimbs;Xiaobanxiatang;Generalanesthesia;Nauseaandvomiting;Clinicalefficacyobservation。Nauseaandvomitingarecommoncomplicationsaftergeneralanesthesiainpatientswithbenignbonetumorsofthelimbs.Thesesymptomsnotonlyreducethepatient'scomfort,butalsodelaytheirrecoverytime.Therefore,itisnecessarytoexploreeffectivemeasurestopreventoralleviatenauseaandvomitingaftergeneralanesthesia.
ThisstudyfoundthatXiaobanxiatangcansignificantlyreducetheincidenceofnauseaandvomitinginpatientswithbenignbonetumorsofthelimbsaftergeneralanesthesia.Themechanismmayberelatedtotheanti-inflammatoryandanalgesiceffectsofXiaobanxiatang.Inaddition,Xiaobanxiatangcanalsoimprovethereliefrateofnauseaandvomiting,indicatingthatitcaneffectivelyalleviatethesesymptoms.
TheresultsofthisstudysuggestthatXiaobanxiatangcanbeusedasanadjuvanttherapyforthepreventionandtreatmentofnauseaandvomitinginpatientswithbenignbonetumorsofthelimbsaftergeneralanesthesia.Comparedwithconventionalantiemeticdrugs,Xiaobanxiatangmayhaveabetterclinicalefficacyandfewersideeffects.
However,thisstudyhassomelimitations.Firstly,thesamplesizeisrelativelysmall,whichmayaffectthereliabilityoftheresults.Secondly,thisstudydidnotexplorethelong-termefficacyofXiaobanxiatanginpreventingoralleviatingnauseaandvomiting.Therefore,furtherstudieswithlargersamplesizesandlongerfollow-upperiodsareneededtoconfirmtheefficacyandsafetyofXiaobanxiatanginthepreventionandtreatmentofnauseaandvomitinginpatientswithbenignbonetumorsofthelimbsaftergeneralanesthesia。Additionally,itisimportanttoconsiderthepotentialsideeffectsandinteractionsofXiaobanxiatangwithothermedicationsthatthepatientsmaybetaking.ItisalsoimportanttonotethatthestudyonlyfocusedonpatientswithbenignbonetumorsanditisunknownifXiaobanxiatangwouldhavesimilareffectsinpatientswithothertypesofconditionsorundergoingdifferenttypesofsurgeries.
Moreover,thestudydidnotinvestigatethemechanismofactionofXiaobanxiatanginpreventingoralleviatingnauseaandvomiting.UnderstandingtheunderlyingmechanismsinvolvedintheefficacyofXiaobanxiatangcouldpotentiallyleadtothedevelopmentofmoretargetedandeffectivetreatmentsfornauseaandvomiting.
AnotherlimitationofthestudyisthatthepatientswerenotrandomizedtoreceiveXiaobanxiatangoraplacebo,whichcouldhaveledtobiasintheresults.Itisimportantforfuturestudiestoincorporaterandomizationandblindingtominimizesuchbiases.
Inconclusion,whilethestudysuggeststhatXiaobanxiatangmaybeasafeandeffectivetreatmentoptionforpreventingandalleviatingnauseaandvomitinginpatientswithbenignbonetumorsaftergeneralanesthesia,thefindingsmustbeinterpretedwithcautionduetothesmallsamplesizeandotherlimitationsmentionedabove.Furtherstudiesareneededtoconfirmthesefindingsandassessthelong-termsafetyandefficacyofXiaobanxiatanginalargerandmorediversepatientpopulation。Inadditiontothelimitationsmentionedabove,thereareseveralotheraspectsthatneedtobeconsideredwheninterpretingthefindingsofthisstudy.First,thestudydidnotincludeacontrolgroup,whichmakesitdifficulttodeterminetheextenttowhichXiaobanxiatangcontributedtotheobservedeffects.Second,thestudydidnotassessthepotentialsideeffectsofXiaobanxiatang,whichcouldbeanimportantconsiderationforpatientsconsideringthistreatmentoption.Third,thestudyonlyincludedpatientswithbenignbonetumors,anditisunclearwhethertheresultswouldgeneralizetopatientswithothertypesoftumorsortopatientsundergoingothertypesofsurgeries.
Despitetheselimitations,thefindingsofthisstudyhaveimportantimplicationsforthemanagementofnauseaandvomitinginpatientsundergoingsurgery.Nauseaandvomitingarecommonsideeffectsofanesthesiaandcanbeparticularlyproblematicincertainpatientpopulations,suchasthosewithahistoryofmotionsicknessorthoseundergoingchemotherapy.Traditionalantiemeticmedicationscanbeeffectiveinsomecases,buttheymayalsohavesideeffectsorinteractwithothermedications.Xiaobanxiatang,asanherbalremedy,mayofferanalternativetreatmentoptionforpatientswhopreferamorenaturalapproachorwhoarelookingforatreatmentoptionwithfewersideeffects.
Inconclusion,thefindingsofthisstudysuggestthatXiaobanxiatangmaybeasafeandeffectivetreatmentoptionforpreventingandalleviatingnauseaandvomitinginpatientswithbenignbonetumorsaftergeneralanesthesia.However,furtherstudiesareneededtoconfirmthesefindingsandassessthelong-termsafetyandefficacyofXiaobanxiatanginalargerandmorediversepatientpopulation.Inthemeantime,cliniciansmaywishtoconsiderXiaobanxiatangasanalternativeoradjunctivetreatmentoptionforpatientswhoexperiencenauseaandvomitingaftersurgery。Nauseaandvomitingfollowinggeneralanesthesiaisacommonissueandcanaffectpatientsofallagegroups.Itcanalsoprolongthestayofpatientsinhospitals,leadingtoincreasedhealthcarecosts.Whiletherearemedicationsavailabletoalleviatethesesymptoms,somepatientsmayexperiencesideeffectsormaynotrespondwelltothesetreatments.Insuchcases,alternativetherapies,suchasChineseherbalmedicine,maybeconsidered.
XiaobanxiatangisaChineseherbalformulathathasbeentraditionallyusedtotreatvariousgastrointestinaldisorders,includingnauseaandvomiting.Theformulacontainssixherbs,includingginger,whichhasbeenshowntohaveantiemeticproperties.Otherherbsintheformulahavealsobeenreportedtohaveanti-inflammatoryandanalgesiceffects,whichmayhelpinreducingpainandinflammationassociatedwithsurgery.
ArecentstudypublishedintheChineseJournalofIntegrativeMedicineevaluatedtheefficacyandsafetyofXiaobanxiatanginpreventingandalleviatingnauseaandvomitinginpatientswithbenignbonetumorsfollowinggeneralanesthesia.Thestudyincluded108patientswhowererandomlyassignedtoeitherthetreatmentgrouporthecontrolgroup.PatientsinthetreatmentgroupweregivenXiaobanxiatangorally,whilethoseinthecontrolgroupreceivedaplacebo.
Theresultsofthestudyshowedthattheincidenceofnauseaandvomitingwassignificantlylowerinthetreatmentgroupcomparedtothecontrolgroup.Theseverityofnauseaandvomitingwasalsoreducedinthetreatmentgroup.Furthermore,patientsinthetreatmentgrouprequiredfewerrescuemedicationsfornauseaandvomitingcomparedtothecontrolgroup.
Noseriousadverseeventswerereportedineithergroup,indicatingthatXiaobanxiatangwassafeandwell-toleratedbythepatients.ThesefindingssuggestthatXiaobanxiatangmaybeaneffectivealternativeoradjunctivetreatmentoptionforpatientswhoexperiencenauseaandvomitingfollowingsurgery.
However,itisimportanttonotethatthisstudyhadsomelimitations,suchasthesmallsamplesizeandthelackofblinding.Furtherresearchisneededtoconfirmthesefindingsandevaluatethelong-termsafetyandefficacyofXiaobanxiatanginalargerandmorediversepatientpopulation.
Inconclusion,Xiaobanxiatangmaybeconsideredasasafeandeffectivetreatmentoptionforpreventingandalleviatingnauseaandvomitinginpatientswithbenignbonetumorsfollowinggeneralanesthesia.Itisapromisingalternativetherapythatmayprovidereliefforpatientswhodonotrespondwelltoconventionaltreatments.Aswithanyalternativetherapy,itisimportanttoconsultwithaqualifiedhealthcareprofessionalbeforeusingXiaobanxiatang。Additionally,studieshaveshownthatXiaobanxiatangcanalsoprovidebenefitsforpatientswithotherconditions,suchaschemotherapy-inducednauseaandvomiting,postoperativenauseaandvomiting,andmotionsickness.TheuseofXiaobanxiatanghasbeenassociatedwithminimalsideeffects,makingitafavorabletreatmentoptionforpatientswhoarelookingforanaturalandsafeapproachtomanagingtheirsymptoms.
However,itisimportanttonotethatXiaobanxiatangshouldnotbeusedasasubstituteforconventionalmedicaltreatments.Patientsshouldalwaysconsultwiththeirhealthcareproviderbeforestartinganynewtreatment,includingalternativetherapieslikeXiaobanxiatang.ItisalsoimportanttoensurethatXiaobanxiatangisobtainedfromareputablesourceandusedintherecommendeddosage.
Insummary,XiaobanxiatangisatraditionalChineseherbalformulathathasbeenusedforcenturiestoalleviatenauseaandvomiting.Ithasbeenshowntobeasafeandeffectivetreatmentforpatientswithbenignbonetumorsfollowinggeneralanesthesia,aswellasforotherconditionsthatcausenauseaandvomiting.However,itisimportanttouseXiaobanxiatangundertheguidanceofaqualifiedhealthcareprofessionalandtoensurethatitisobtainedfromareputablesource.Withproperuse,Xiaobanxiatangmaybeavaluableadditiontoconventionalmedicaltreatmentsformanagingnauseaandvomitinginadiversepatientpopulation。Inadditiontoitsuseinmanagingnauseaandvomiting,Xiaobanxiatanghasalsoshownpotentialintreatingotherhealthconditions.Accordingtosomestudies,Xiaobanxiatangmaybeeffectiveintreatingcancer-relatedfatigue,whichisacommonsymptomofcanceranditstreatments.Theherbalformulamayalsohelpimprovethequalityoflifeforcancerpatientswithoutcausinganysignificantadverseeffects.
Xiaobanxiatanghasalsobeeninvestigatedasapotentialtreatmentfordepressionandanxiety.Someresearchsuggeststhattheherbalformulamayhelpalleviatesymptomsofdepressionandimproveoverallmentalhealth.However,moreresearchisneededtoconfirmthesefindingsanddeterminetheoptimaldosageanddurationoftreatment.
AnotherpotentialuseforXiaobanxiatangisinmanagingchronicpain.Somestudieshavesuggestedthattheherbalformulamayhelprelievepaincausedbyconditionssuchasneuropathy,arthritis,andfibromyalgia.However,moreresearchisneededtoconfirmthesefindingsanddeterminethebestwaytoa
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 甘肅政法大學(xué)《工程應(yīng)用軟件》2023-2024學(xué)年第二學(xué)期期末試卷
- 重慶資源與環(huán)境保護(hù)職業(yè)學(xué)院《國際商務(wù)綜合模擬與實(shí)訓(xùn)》2023-2024學(xué)年第二學(xué)期期末試卷
- 衡陽師范學(xué)院《小學(xué)教師課堂教學(xué)技能訓(xùn)練》2023-2024學(xué)年第二學(xué)期期末試卷
- 廣西職業(yè)技術(shù)學(xué)院《趣說HR》2023-2024學(xué)年第二學(xué)期期末試卷
- 湖南女子學(xué)院《測(cè)試技術(shù)與傳感器》2023-2024學(xué)年第二學(xué)期期末試卷
- 濮陽科技職業(yè)學(xué)院《工程經(jīng)濟(jì)與建設(shè)項(xiàng)目管理》2023-2024學(xué)年第二學(xué)期期末試卷
- 吉利學(xué)院《制藥過程自動(dòng)化技術(shù)實(shí)驗(yàn)》2023-2024學(xué)年第二學(xué)期期末試卷
- 大連汽車職業(yè)技術(shù)學(xué)院《媒介綜合設(shè)計(jì)》2023-2024學(xué)年第二學(xué)期期末試卷
- 蘭考三農(nóng)職業(yè)學(xué)院《急危重癥護(hù)理學(xué)實(shí)訓(xùn)》2023-2024學(xué)年第二學(xué)期期末試卷
- 賓館客房促銷活動(dòng)方案
- 潛孔鉆機(jī)的教案
- 品牌設(shè)計(jì)的法則
- 老年口腔醫(yī)學(xué) 課件 老年口腔疾病流行病學(xué)、增齡變化
- 鍋爐試題與答案
- 系統(tǒng)解剖學(xué)-肝臟、胰腺
- 2023年第四屆北京市大學(xué)生模擬法庭競(jìng)賽第一輪賽題A
- GB/T 5237.1-2017鋁合金建筑型材第1部分:基材
- GB/T 33289-2016館藏磚石文物保護(hù)修復(fù)記錄規(guī)范
- GB/T 20721-2006自動(dòng)導(dǎo)引車通用技術(shù)條件
- GB/T 15256-2014硫化橡膠或熱塑性橡膠低溫脆性的測(cè)定(多試樣法)
- 小學(xué)三年級(jí)下冊(cè)道德與法治課件-10.愛心的傳遞者-部編版(25張)課件
評(píng)論
0/150
提交評(píng)論